Daniel Erku is a pharmacist and public health researcher, with training and experience in using (pharmaco) economic evaluations to inform health policies and improve outcomes for patients. Since 2016, he has published over 45 original articles in high impact medical journals, in the areas of pharmaceutical health services research (including clinical, economic, and patient-reported outcomes), and health policy analysis in cancer prevention and control (e.g. tobacco control policies). Before he moved to Australia to pursue his PhD in Public Health at the University of Queensland (2018-2020), he worked as a faculty at the University of Gondar in Ethiopia (2015-2018), teaching courses related to medicine access issues, pharmacoepidemiology, pharmacotherapy, and pharmacy practice.

He developed the Ethiopian Chapter of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR-Ethiopia Chapter) and served as President from 2017-2020. He is a member of ISPOR Africa Network Executive Committee. The ISPOR Africa Network is a group within the organizational structure of ISPOR and is a forum for regional chapter members interested in the science of health economics and outcomes research and its use in healthcare policies and decisions in Africa region.

Currently Daniel is a Postdoctoral Research Fellow (Health Economics) within Menzies Health Institute Queensland, Griffith University, working on the health economics component of ACRE’s research projects using observational data collected via the pharmacovigilance and survey data, and early phase clinical pharmacology studies.

Daniel is a member of the ACRE Capacity Building Group.